Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Abbott scientists impart novel vanilloid VR1 receptor inhibitors for pain therapy

March 1, 2005

Coagulation factor VIIa inhibitors developed by Bristol-Myers Squibb

March 1, 2005

Novel Streptomyces-derived antitumor agents discovered at Ecopia BioSciences

March 1, 2005

Pfizer reports new SSRIs for premature ejaculation and other disorders

March 1, 2005

Novel MMP inhibitors discovered by GlaxoSmithKline

Feb. 28, 2005

New inhibitors of MHC class I expression described by Nippon Kayaku scientists

Feb. 28, 2005

Anti-human papillomavirus (HPV) agents claimed by GSK

Feb. 28, 2005

Vertex presents ABC transporter modulators for use in cystic fibrosis therapy

Feb. 28, 2005

New PPARdelta/PPARalpha agonists disclosed by Roche

Feb. 28, 2005

Novel DPP-IV inhibitors for type 2 diabetes reported by Merck

Feb. 28, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...